Showing results (1-10 of 411) with videos related to
Sort By:
Pageof 42
Cancer Cell|November 10, 2020
Tumor Mutational Burden as a Pan-cancer Biomarker for Immunotherapy: The Limits and Potential for ConvergenceAntonio Passaro, Albrecht Stenzinger, Solange PetersJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2023
Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing StrategiesAntonio Passaro, Pasi A Jänne, Solange PetersCancer Discovery|April 3, 2021
The Promising Evolution of Targeted Therapeutic Strategies in CancerSolange Peters, Tony Mok, Antonio Passaro, et al.Nature Cancer|February 5, 2022
Overcoming therapy resistance in EGFR-mutant lung cancerAntonio Passaro, Pasi A Jänne, Tony Mok, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2022
Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel StrategiesAntonio Passaro, Julie Brahmer, Scott Antonia, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2020
Recent Advances on the Role of EGFR Tyrosine Kinase Inhibitors in the Management of NSCLC With Uncommon, Non Exon 20 Insertions, EGFR MutationsAntonio Passaro, Tony Mok, Solange Peters, et al.Journal for Immunotherapy of Cancer|March 19, 2021
Severity of COVID-19 in patients with lung cancer: evidence and challengesAntonio Passaro, Christine Bestvina, Maria Velez Velez, et al.JAMA Oncology|May 11, 2023
Adjuvant Treatments for Surgically Resected Non-Small Cell Lung Cancer Harboring EGFR Mutations: A ReviewAntonio Passaro, Tony S K Mok, Ilaria Attili, et al.ESMO Open|June 26, 2020
ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancerAntonio Passaro, Alfredo Addeo, Christophe Von Garnier, et al.Cell|March 29, 2024
Cancer biomarkers: Emerging trends and clinical implications for personalized treatmentAntonio Passaro, Maise Al Bakir, Emily G Hamilton, et al.Pageof 42